Loading…
Welcome to the Science Summit at the United Nations General Assembly (UNGA77)

Please Register by clicking HERE

Registration is free of charge. You can register yourself and also other colleagues (up to 10 people).

After you have registered, you will receive two emails: one from Eventbrite with your ticket, and 15 min later, one from SCHED inviting you to create your username and password (these will be your  SCHED login details to access the conference each time).

Once you have your SCHED login details, you can select the session(s) you would like to attend and be able to see the ZOOM link to join your selected sessions.

All times in the AGENDA are New York Local (Eastern Daylight Time (EDT)). To view times in another time zone, please use the "Timezone" box located below on the right.
Back To Schedule
Tuesday, September 27 • 2:00pm - 4:00pm
(REF 27219 - Hybrid) Biobanking for Bangladesh - Convened by Bangabandhu Sheikh Mujib Medical University (BSMMU)

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Add to your schedule to access the video stream

JOIN ONLINE SESSION
https://us02web.zoom.us/j/86879534170?pwd=R0xzZ1lEQ2JIaU5hQ1hOc05LTGluZz09

Biobanking for Bangladesh - Convened by Bangabandhu Sheikh Mujib Medical University (BSMMU)

In person event at The Permanent Mission of the People's Republic of Bangladesh to the United Nations, 820 2nd Ave 4th floor, New York, NY 10017

Abstract
The importance of an international standard biobank in Bangladesh has enormous potential for future research. Since the clinical consequences of genetic and molecular alterations differ with patient race and ethnicity, the usefulness of these molecular alterations as biomarkers/drug development needs to be evaluated in different racial/ ethnic groups. Various factors, including cellular and molecular heterogeneity within tumors, varying host immune responses, diet, environmental exposure, lifestyle, and patient demographics, influence the effectiveness of cancer drugs/biomarkers.

Thus, the one-size-fits-all approach is obsolete, and there is a need to design strategies to develop effective drugs/biomarkers by applying principles of individualised cancer care. It is well known that racial disparities exist in drug/biomarker testing and clinical trial enrolment, as most of the approved cancer drugs/biomarkers have been tested on Caucasian populations. The lack of reliable/trustworthy biomaterial with clinical data is one of the primary reasons why many Asian countries are underrepresented in biomarker studies.

Our proposal aims to address this grand challenge by establishing a biobank and research facility at BSSMU/Bangladesh that will ensure long-term clinical research collaboration with top universities worldwide. This initiative could set up an example of how to strengthen academic scientific research in developing countries in accordance with the United Nations Sustainable Development Goals (SDGs) to ensure inclusiveness in science at the global level.
2.00 pm - 2.10 pmWelcome and introduction
Declan Kirrane, Chairman, Science Summit at United Nations General Assembly (SSUNGA77), Managing Director, Africa-Europe Science Collaboration and Innovation Platform.2.10 pm - 2.35pmBiobanking and global health challenges
Prof. Kurt Zatloukal, Director of BBMRI.at, Head of the Diagnostic and Research
Center for Molecular Biomedicine, Medical University of Graz, Graz, Austria.2.35 pm - 3.00 pmBiobanking international networks, collaborative projects, and prospects
Dr. Zisis Kozlakidis, Head, Laboratory Services and Biobank Group, World Health Organization, International Agency for Research on Cancer, Lyon, France3.00 pm - 3.20 pmHealth infrastructure of Bangladesh: opportunities for BSSMU to lead translational research in the region
Prof. Md. Sharfuddin Ahmed, Vice-Chancellor, BSMMU*3.20 pm - 3.45 pmBiobanks: A pillar in precision medicine; Qatar Biobank experience
Professor Asmaa Al Thani, Vice President for Health and Medical Sciences and Director of Biomedical Research Center
Dr. Nahla Afifi, Director of Qatar Biobank3.45 pm - 4.05 pmThe Role of Biobank in the development of translational research
Dr. Arman Rahman, Assistant Professor, School of Medicine, UCD, Ireland4.05 pm - 4.25 pmCurrent research infrastructure at BSSMU, how a biobank can improve current research practice
Prof. Laila Anjuman Banu, Professor of Genetics and Molecular Biology, Chairman, Department of Anatomy, BSMMU4.25 pm - 4.50 pmBiobanking and international sharing for research, ethical and legal implications
Dr. Rita Lawlor, Biobank and Model Bank Director, Research Centre Coordinator, Centre for Applied Research on Cancer, University of Verona.4.50 pm – 5.10 pmEthics and legal framework of Bangladeshi/south Asian law for biobanking
Prof. Md. Sayedur Rahman, Professor, and Chairman, Department of Pharmacology, BSMMU

Speakers
avatar for Kurt Zatloukal

Kurt Zatloukal

Prof. of Pathology, Medical University of Graz
Kurt Zatloukal, M.D.  is professor of pathology at the Medical University of Graz, Austria and is head of the Diagnostic and Research Center for Molecular Biomedicine. His research focusses on molecular pathology of diseases as well as biobanking and related technologies. He coordinated... Read More →
avatar for Rita Lawlor

Rita Lawlor

Biobank Director, ARC-Net, University of Verona
Rita Lawlor is a Computer Science graduate of Trinity College Dublin with a doctorate in Oncological Pathology from the University of Verona where she is co-founder of the ARC-Net (www.arc-net.it) applied cancer research centre where is director of the ARC-Net biobank and coordinates... Read More →
avatar for Arman Rahman

Arman Rahman

Assistant Professor, UCD
Dr. Arman RahmanA Bangladeshi Irish cancer researcher, Dr. Rahman works as an assistant professor at University College Dublin (UCD) School of Medicine and is responsible for Precision Oncology Ireland's Tissue Imaging Platform. After finishing his Ph.D. in Immunology from Umea University... Read More →


Tuesday September 27, 2022 2:00pm - 4:00pm EDT
Hybrid
  Health and Medicine, Medicine
Feedback form isn't open yet.